nodes	percent_of_prediction	percent_of_DWPC	metapath
Colestipol—Musculoskeletal discomfort—Captopril—systemic scleroderma	0.00261	0.00261	CcSEcCtD
Colestipol—Arthralgia—Azathioprine—systemic scleroderma	0.00261	0.00261	CcSEcCtD
Colestipol—Vertigo—Leflunomide—systemic scleroderma	0.0026	0.0026	CcSEcCtD
Colestipol—Insomnia—Captopril—systemic scleroderma	0.00259	0.00259	CcSEcCtD
Colestipol—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—systemic scleroderma	0.00259	0.00259	CcSEcCtD
Colestipol—Diarrhoea—Pentoxifylline—systemic scleroderma	0.00258	0.00258	CcSEcCtD
Colestipol—Abdominal pain—Mometasone—systemic scleroderma	0.00258	0.00258	CcSEcCtD
Colestipol—Mediastinal disorder—Lisinopril—systemic scleroderma	0.00257	0.00257	CcSEcCtD
Colestipol—Dyspnoea—Captopril—systemic scleroderma	0.00255	0.00255	CcSEcCtD
Colestipol—Somnolence—Captopril—systemic scleroderma	0.00254	0.00254	CcSEcCtD
Colestipol—Dyspepsia—Captopril—systemic scleroderma	0.00252	0.00252	CcSEcCtD
Colestipol—Mental disorder—Lisinopril—systemic scleroderma	0.0025	0.0025	CcSEcCtD
Colestipol—Dizziness—Pentoxifylline—systemic scleroderma	0.0025	0.0025	CcSEcCtD
Colestipol—Decreased appetite—Captopril—systemic scleroderma	0.00249	0.00249	CcSEcCtD
Colestipol—Malnutrition—Lisinopril—systemic scleroderma	0.00248	0.00248	CcSEcCtD
Colestipol—Vertigo—Mycophenolic acid—systemic scleroderma	0.00248	0.00248	CcSEcCtD
Colestipol—Fatigue—Captopril—systemic scleroderma	0.00247	0.00247	CcSEcCtD
Colestipol—Oedema peripheral—Mycophenolate mofetil—systemic scleroderma	0.00246	0.00246	CcSEcCtD
Colestipol—Arthralgia—Leflunomide—systemic scleroderma	0.00246	0.00246	CcSEcCtD
Colestipol—Chest pain—Leflunomide—systemic scleroderma	0.00246	0.00246	CcSEcCtD
Colestipol—Connective tissue disorder—Mycophenolate mofetil—systemic scleroderma	0.00246	0.00246	CcSEcCtD
Colestipol—Anxiety—Leflunomide—systemic scleroderma	0.00245	0.00245	CcSEcCtD
Colestipol—Gastrointestinal haemorrhage—Prednisone—systemic scleroderma	0.00245	0.00245	CcSEcCtD
Colestipol—Constipation—Captopril—systemic scleroderma	0.00245	0.00245	CcSEcCtD
Colestipol—Flatulence—Lisinopril—systemic scleroderma	0.00245	0.00245	CcSEcCtD
Colestipol—Unspecified disorder of skin and subcutaneous tissue—Leflunomide—systemic scleroderma	0.00244	0.00244	CcSEcCtD
Colestipol—Skin disorder—Azathioprine—systemic scleroderma	0.00243	0.00243	CcSEcCtD
Colestipol—Back pain—Lisinopril—systemic scleroderma	0.0024	0.0024	CcSEcCtD
Colestipol—Vomiting—Pentoxifylline—systemic scleroderma	0.0024	0.0024	CcSEcCtD
Colestipol—Muscle spasms—Lisinopril—systemic scleroderma	0.00239	0.00239	CcSEcCtD
Colestipol—Rash—Pentoxifylline—systemic scleroderma	0.00238	0.00238	CcSEcCtD
Colestipol—Dermatitis—Pentoxifylline—systemic scleroderma	0.00238	0.00238	CcSEcCtD
Colestipol—Headache—Pentoxifylline—systemic scleroderma	0.00237	0.00237	CcSEcCtD
Colestipol—Arthralgia—Mycophenolic acid—systemic scleroderma	0.00235	0.00235	CcSEcCtD
Colestipol—Chest pain—Mycophenolic acid—systemic scleroderma	0.00235	0.00235	CcSEcCtD
Colestipol—Gastrointestinal pain—Captopril—systemic scleroderma	0.00234	0.00234	CcSEcCtD
Colestipol—Anxiety—Mycophenolic acid—systemic scleroderma	0.00234	0.00234	CcSEcCtD
Colestipol—Asthenia—Mometasone—systemic scleroderma	0.00234	0.00234	CcSEcCtD
Colestipol—Unspecified disorder of skin and subcutaneous tissue—Mycophenolic acid—systemic scleroderma	0.00233	0.00233	CcSEcCtD
Colestipol—Cardiac disorder—Mycophenolate mofetil—systemic scleroderma	0.00232	0.00232	CcSEcCtD
Colestipol—Nervous system disorder—Leflunomide—systemic scleroderma	0.00231	0.00231	CcSEcCtD
Colestipol—Tachycardia—Leflunomide—systemic scleroderma	0.0023	0.0023	CcSEcCtD
Colestipol—Skin disorder—Leflunomide—systemic scleroderma	0.00229	0.00229	CcSEcCtD
Colestipol—Musculoskeletal discomfort—Azathioprine—systemic scleroderma	0.00228	0.00228	CcSEcCtD
Colestipol—Abdominal pain—Captopril—systemic scleroderma	0.00226	0.00226	CcSEcCtD
Colestipol—Mediastinal disorder—Mycophenolate mofetil—systemic scleroderma	0.00225	0.00225	CcSEcCtD
Colestipol—Anorexia—Leflunomide—systemic scleroderma	0.00225	0.00225	CcSEcCtD
Colestipol—Nausea—Pentoxifylline—systemic scleroderma	0.00224	0.00224	CcSEcCtD
Colestipol—Vertigo—Lisinopril—systemic scleroderma	0.00223	0.00223	CcSEcCtD
Colestipol—Diarrhoea—Mometasone—systemic scleroderma	0.00223	0.00223	CcSEcCtD
Colestipol—Nervous system disorder—Mycophenolic acid—systemic scleroderma	0.00221	0.00221	CcSEcCtD
Colestipol—Tachycardia—Mycophenolic acid—systemic scleroderma	0.0022	0.0022	CcSEcCtD
Colestipol—Mental disorder—Mycophenolate mofetil—systemic scleroderma	0.00219	0.00219	CcSEcCtD
Colestipol—Skin disorder—Mycophenolic acid—systemic scleroderma	0.00219	0.00219	CcSEcCtD
Colestipol—Malnutrition—Mycophenolate mofetil—systemic scleroderma	0.00218	0.00218	CcSEcCtD
Colestipol—Alanine aminotransferase increased—Prednisone—systemic scleroderma	0.00216	0.00216	CcSEcCtD
Colestipol—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.00216	0.00216	CcSEcCtD
Colestipol—Musculoskeletal discomfort—Leflunomide—systemic scleroderma	0.00215	0.00215	CcSEcCtD
Colestipol—Anorexia—Mycophenolic acid—systemic scleroderma	0.00215	0.00215	CcSEcCtD
Colestipol—Flatulence—Mycophenolate mofetil—systemic scleroderma	0.00214	0.00214	CcSEcCtD
Colestipol—Insomnia—Leflunomide—systemic scleroderma	0.00213	0.00213	CcSEcCtD
Colestipol—Abdominal distension—Prednisone—systemic scleroderma	0.00213	0.00213	CcSEcCtD
Colestipol—Arthralgia—Lisinopril—systemic scleroderma	0.00211	0.00211	CcSEcCtD
Colestipol—Chest pain—Lisinopril—systemic scleroderma	0.00211	0.00211	CcSEcCtD
Colestipol—Anxiety—Lisinopril—systemic scleroderma	0.00211	0.00211	CcSEcCtD
Colestipol—Back pain—Mycophenolate mofetil—systemic scleroderma	0.0021	0.0021	CcSEcCtD
Colestipol—Dyspnoea—Leflunomide—systemic scleroderma	0.0021	0.0021	CcSEcCtD
Colestipol—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—systemic scleroderma	0.0021	0.0021	CcSEcCtD
Colestipol—Muscle spasms—Mycophenolate mofetil—systemic scleroderma	0.00209	0.00209	CcSEcCtD
Colestipol—Dyspepsia—Leflunomide—systemic scleroderma	0.00208	0.00208	CcSEcCtD
Colestipol—Vomiting—Mometasone—systemic scleroderma	0.00207	0.00207	CcSEcCtD
Colestipol—Rash—Mometasone—systemic scleroderma	0.00205	0.00205	CcSEcCtD
Colestipol—Asthenia—Captopril—systemic scleroderma	0.00205	0.00205	CcSEcCtD
Colestipol—Dermatitis—Mometasone—systemic scleroderma	0.00205	0.00205	CcSEcCtD
Colestipol—Decreased appetite—Leflunomide—systemic scleroderma	0.00205	0.00205	CcSEcCtD
Colestipol—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.00205	0.00205	CcSEcCtD
Colestipol—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.00204	0.00204	CcSEcCtD
Colestipol—Headache—Mometasone—systemic scleroderma	0.00204	0.00204	CcSEcCtD
Colestipol—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.00204	0.00204	CcSEcCtD
Colestipol—Insomnia—Mycophenolic acid—systemic scleroderma	0.00204	0.00204	CcSEcCtD
Colestipol—Fatigue—Leflunomide—systemic scleroderma	0.00203	0.00203	CcSEcCtD
Colestipol—Pain—Leflunomide—systemic scleroderma	0.00202	0.00202	CcSEcCtD
Colestipol—Constipation—Leflunomide—systemic scleroderma	0.00202	0.00202	CcSEcCtD
Colestipol—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.00201	0.00201	CcSEcCtD
Colestipol—Somnolence—Mycophenolic acid—systemic scleroderma	0.002	0.002	CcSEcCtD
Colestipol—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.00198	0.00198	CcSEcCtD
Colestipol—Tachycardia—Lisinopril—systemic scleroderma	0.00198	0.00198	CcSEcCtD
Colestipol—Abdominal pain—Azathioprine—systemic scleroderma	0.00197	0.00197	CcSEcCtD
Colestipol—Skin disorder—Lisinopril—systemic scleroderma	0.00197	0.00197	CcSEcCtD
Colestipol—Diarrhoea—Captopril—systemic scleroderma	0.00196	0.00196	CcSEcCtD
Colestipol—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.00196	0.00196	CcSEcCtD
Colestipol—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.00196	0.00196	CcSEcCtD
Colestipol—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.00194	0.00194	CcSEcCtD
Colestipol—Fatigue—Mycophenolic acid—systemic scleroderma	0.00194	0.00194	CcSEcCtD
Colestipol—Nausea—Mometasone—systemic scleroderma	0.00194	0.00194	CcSEcCtD
Colestipol—Anorexia—Lisinopril—systemic scleroderma	0.00193	0.00193	CcSEcCtD
Colestipol—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.00193	0.00193	CcSEcCtD
Colestipol—Constipation—Mycophenolic acid—systemic scleroderma	0.00192	0.00192	CcSEcCtD
Colestipol—Pain—Mycophenolic acid—systemic scleroderma	0.00192	0.00192	CcSEcCtD
Colestipol—Dizziness—Captopril—systemic scleroderma	0.00189	0.00189	CcSEcCtD
Colestipol—Urticaria—Leflunomide—systemic scleroderma	0.00187	0.00187	CcSEcCtD
Colestipol—Abdominal pain—Leflunomide—systemic scleroderma	0.00186	0.00186	CcSEcCtD
Colestipol—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.00185	0.00185	CcSEcCtD
Colestipol—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.00185	0.00185	CcSEcCtD
Colestipol—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.00185	0.00185	CcSEcCtD
Colestipol—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.00185	0.00185	CcSEcCtD
Colestipol—Hypersensitivity—Azathioprine—systemic scleroderma	0.00184	0.00184	CcSEcCtD
Colestipol—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.00184	0.00184	CcSEcCtD
Colestipol—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.00184	0.00184	CcSEcCtD
Colestipol—Insomnia—Lisinopril—systemic scleroderma	0.00183	0.00183	CcSEcCtD
Colestipol—Vomiting—Captopril—systemic scleroderma	0.00182	0.00182	CcSEcCtD
Colestipol—Dyspnoea—Lisinopril—systemic scleroderma	0.00181	0.00181	CcSEcCtD
Colestipol—Rash—Captopril—systemic scleroderma	0.0018	0.0018	CcSEcCtD
Colestipol—Dermatitis—Captopril—systemic scleroderma	0.0018	0.0018	CcSEcCtD
Colestipol—Somnolence—Lisinopril—systemic scleroderma	0.0018	0.0018	CcSEcCtD
Colestipol—Headache—Captopril—systemic scleroderma	0.00179	0.00179	CcSEcCtD
Colestipol—Dyspepsia—Lisinopril—systemic scleroderma	0.00178	0.00178	CcSEcCtD
Colestipol—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.00178	0.00178	CcSEcCtD
Colestipol—Decreased appetite—Lisinopril—systemic scleroderma	0.00176	0.00176	CcSEcCtD
Colestipol—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.00175	0.00175	CcSEcCtD
Colestipol—Fatigue—Lisinopril—systemic scleroderma	0.00175	0.00175	CcSEcCtD
Colestipol—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.00174	0.00174	CcSEcCtD
Colestipol—Hypersensitivity—Leflunomide—systemic scleroderma	0.00174	0.00174	CcSEcCtD
Colestipol—Pain—Lisinopril—systemic scleroderma	0.00173	0.00173	CcSEcCtD
Colestipol—Constipation—Lisinopril—systemic scleroderma	0.00173	0.00173	CcSEcCtD
Colestipol—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.00173	0.00173	CcSEcCtD
Colestipol—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.00173	0.00173	CcSEcCtD
Colestipol—Diarrhoea—Azathioprine—systemic scleroderma	0.00171	0.00171	CcSEcCtD
Colestipol—Nausea—Captopril—systemic scleroderma	0.0017	0.0017	CcSEcCtD
Colestipol—Abdominal discomfort—Methotrexate—systemic scleroderma	0.0017	0.0017	CcSEcCtD
Colestipol—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.00169	0.00169	CcSEcCtD
Colestipol—Asthenia—Leflunomide—systemic scleroderma	0.00169	0.00169	CcSEcCtD
Colestipol—Connective tissue disorder—Prednisone—systemic scleroderma	0.00167	0.00167	CcSEcCtD
Colestipol—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.00166	0.00166	CcSEcCtD
Colestipol—Dizziness—Azathioprine—systemic scleroderma	0.00165	0.00165	CcSEcCtD
Colestipol—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.00162	0.00162	CcSEcCtD
Colestipol—Asthenia—Mycophenolic acid—systemic scleroderma	0.00161	0.00161	CcSEcCtD
Colestipol—Diarrhoea—Leflunomide—systemic scleroderma	0.00161	0.00161	CcSEcCtD
Colestipol—Urticaria—Lisinopril—systemic scleroderma	0.00161	0.00161	CcSEcCtD
Colestipol—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.00161	0.00161	CcSEcCtD
Colestipol—Abdominal pain—Lisinopril—systemic scleroderma	0.0016	0.0016	CcSEcCtD
Colestipol—Vomiting—Azathioprine—systemic scleroderma	0.00159	0.00159	CcSEcCtD
Colestipol—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.00158	0.00158	CcSEcCtD
Colestipol—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.00158	0.00158	CcSEcCtD
Colestipol—Drowsiness—Methotrexate—systemic scleroderma	0.00158	0.00158	CcSEcCtD
Colestipol—Rash—Azathioprine—systemic scleroderma	0.00158	0.00158	CcSEcCtD
Colestipol—Dermatitis—Azathioprine—systemic scleroderma	0.00157	0.00157	CcSEcCtD
Colestipol—Headache—Azathioprine—systemic scleroderma	0.00156	0.00156	CcSEcCtD
Colestipol—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.00156	0.00156	CcSEcCtD
Colestipol—Dizziness—Leflunomide—systemic scleroderma	0.00156	0.00156	CcSEcCtD
Colestipol—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.00154	0.00154	CcSEcCtD
Colestipol—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.00154	0.00154	CcSEcCtD
Colestipol—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.00153	0.00153	CcSEcCtD
Colestipol—Pain—Mycophenolate mofetil—systemic scleroderma	0.00152	0.00152	CcSEcCtD
Colestipol—Constipation—Mycophenolate mofetil—systemic scleroderma	0.00152	0.00152	CcSEcCtD
Colestipol—Vomiting—Leflunomide—systemic scleroderma	0.0015	0.0015	CcSEcCtD
Colestipol—Hypersensitivity—Lisinopril—systemic scleroderma	0.00149	0.00149	CcSEcCtD
Colestipol—Hepatobiliary disease—Methotrexate—systemic scleroderma	0.00149	0.00149	CcSEcCtD
Colestipol—Dizziness—Mycophenolic acid—systemic scleroderma	0.00149	0.00149	CcSEcCtD
Colestipol—Rash—Leflunomide—systemic scleroderma	0.00149	0.00149	CcSEcCtD
Colestipol—Dermatitis—Leflunomide—systemic scleroderma	0.00149	0.00149	CcSEcCtD
Colestipol—Mental disorder—Prednisone—systemic scleroderma	0.00148	0.00148	CcSEcCtD
Colestipol—Nausea—Azathioprine—systemic scleroderma	0.00148	0.00148	CcSEcCtD
Colestipol—Headache—Leflunomide—systemic scleroderma	0.00148	0.00148	CcSEcCtD
Colestipol—Malnutrition—Prednisone—systemic scleroderma	0.00148	0.00148	CcSEcCtD
Colestipol—Asthenia—Lisinopril—systemic scleroderma	0.00145	0.00145	CcSEcCtD
Colestipol—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.00145	0.00145	CcSEcCtD
Colestipol—Vomiting—Mycophenolic acid—systemic scleroderma	0.00143	0.00143	CcSEcCtD
Colestipol—Rash—Mycophenolic acid—systemic scleroderma	0.00142	0.00142	CcSEcCtD
Colestipol—Dermatitis—Mycophenolic acid—systemic scleroderma	0.00142	0.00142	CcSEcCtD
Colestipol—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.00141	0.00141	CcSEcCtD
Colestipol—Headache—Mycophenolic acid—systemic scleroderma	0.00141	0.00141	CcSEcCtD
Colestipol—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.0014	0.0014	CcSEcCtD
Colestipol—Nausea—Leflunomide—systemic scleroderma	0.0014	0.0014	CcSEcCtD
Colestipol—Diarrhoea—Lisinopril—systemic scleroderma	0.00139	0.00139	CcSEcCtD
Colestipol—Dizziness—Lisinopril—systemic scleroderma	0.00134	0.00134	CcSEcCtD
Colestipol—Nausea—Mycophenolic acid—systemic scleroderma	0.00134	0.00134	CcSEcCtD
Colestipol—Vertigo—Prednisone—systemic scleroderma	0.00133	0.00133	CcSEcCtD
Colestipol—Cardiac disorder—Methotrexate—systemic scleroderma	0.00131	0.00131	CcSEcCtD
Colestipol—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.00131	0.00131	CcSEcCtD
Colestipol—Vomiting—Lisinopril—systemic scleroderma	0.00129	0.00129	CcSEcCtD
Colestipol—Rash—Lisinopril—systemic scleroderma	0.00128	0.00128	CcSEcCtD
Colestipol—Dermatitis—Lisinopril—systemic scleroderma	0.00128	0.00128	CcSEcCtD
Colestipol—Mediastinal disorder—Methotrexate—systemic scleroderma	0.00128	0.00128	CcSEcCtD
Colestipol—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.00127	0.00127	CcSEcCtD
Colestipol—Headache—Lisinopril—systemic scleroderma	0.00127	0.00127	CcSEcCtD
Colestipol—Arthralgia—Prednisone—systemic scleroderma	0.00126	0.00126	CcSEcCtD
Colestipol—Anxiety—Prednisone—systemic scleroderma	0.00125	0.00125	CcSEcCtD
Colestipol—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.00125	0.00125	CcSEcCtD
Colestipol—Mental disorder—Methotrexate—systemic scleroderma	0.00124	0.00124	CcSEcCtD
Colestipol—Malnutrition—Methotrexate—systemic scleroderma	0.00123	0.00123	CcSEcCtD
Colestipol—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.00122	0.00122	CcSEcCtD
Colestipol—Nausea—Lisinopril—systemic scleroderma	0.0012	0.0012	CcSEcCtD
Colestipol—Back pain—Methotrexate—systemic scleroderma	0.00119	0.00119	CcSEcCtD
Colestipol—Nervous system disorder—Prednisone—systemic scleroderma	0.00118	0.00118	CcSEcCtD
Colestipol—Tachycardia—Prednisone—systemic scleroderma	0.00117	0.00117	CcSEcCtD
Colestipol—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.00117	0.00117	CcSEcCtD
Colestipol—Skin disorder—Prednisone—systemic scleroderma	0.00117	0.00117	CcSEcCtD
Colestipol—Anorexia—Prednisone—systemic scleroderma	0.00115	0.00115	CcSEcCtD
Colestipol—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.00113	0.00113	CcSEcCtD
Colestipol—Rash—Mycophenolate mofetil—systemic scleroderma	0.00112	0.00112	CcSEcCtD
Colestipol—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.00112	0.00112	CcSEcCtD
Colestipol—Headache—Mycophenolate mofetil—systemic scleroderma	0.00111	0.00111	CcSEcCtD
Colestipol—Vertigo—Methotrexate—systemic scleroderma	0.00111	0.00111	CcSEcCtD
Colestipol—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.0011	0.0011	CcSEcCtD
Colestipol—Insomnia—Prednisone—systemic scleroderma	0.00109	0.00109	CcSEcCtD
Colestipol—Dyspepsia—Prednisone—systemic scleroderma	0.00106	0.00106	CcSEcCtD
Colestipol—Nausea—Mycophenolate mofetil—systemic scleroderma	0.00105	0.00105	CcSEcCtD
Colestipol—Chest pain—Methotrexate—systemic scleroderma	0.00105	0.00105	CcSEcCtD
Colestipol—Arthralgia—Methotrexate—systemic scleroderma	0.00105	0.00105	CcSEcCtD
Colestipol—Decreased appetite—Prednisone—systemic scleroderma	0.00105	0.00105	CcSEcCtD
Colestipol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.00104	0.00104	CcSEcCtD
Colestipol—Fatigue—Prednisone—systemic scleroderma	0.00104	0.00104	CcSEcCtD
Colestipol—Constipation—Prednisone—systemic scleroderma	0.00103	0.00103	CcSEcCtD
Colestipol—Nervous system disorder—Methotrexate—systemic scleroderma	0.000987	0.000987	CcSEcCtD
Colestipol—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000984	0.000984	CcSEcCtD
Colestipol—Skin disorder—Methotrexate—systemic scleroderma	0.000977	0.000977	CcSEcCtD
Colestipol—Anorexia—Methotrexate—systemic scleroderma	0.000959	0.000959	CcSEcCtD
Colestipol—Urticaria—Prednisone—systemic scleroderma	0.000956	0.000956	CcSEcCtD
Colestipol—Abdominal pain—Prednisone—systemic scleroderma	0.000952	0.000952	CcSEcCtD
Colestipol—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000917	0.000917	CcSEcCtD
Colestipol—Insomnia—Methotrexate—systemic scleroderma	0.00091	0.00091	CcSEcCtD
Colestipol—Dyspnoea—Methotrexate—systemic scleroderma	0.000897	0.000897	CcSEcCtD
Colestipol—Somnolence—Methotrexate—systemic scleroderma	0.000894	0.000894	CcSEcCtD
Colestipol—Hypersensitivity—Prednisone—systemic scleroderma	0.000887	0.000887	CcSEcCtD
Colestipol—Dyspepsia—Methotrexate—systemic scleroderma	0.000886	0.000886	CcSEcCtD
Colestipol—Decreased appetite—Methotrexate—systemic scleroderma	0.000875	0.000875	CcSEcCtD
Colestipol—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000869	0.000869	CcSEcCtD
Colestipol—Fatigue—Methotrexate—systemic scleroderma	0.000867	0.000867	CcSEcCtD
Colestipol—Asthenia—Prednisone—systemic scleroderma	0.000864	0.000864	CcSEcCtD
Colestipol—Pain—Methotrexate—systemic scleroderma	0.00086	0.00086	CcSEcCtD
Colestipol—Diarrhoea—Prednisone—systemic scleroderma	0.000824	0.000824	CcSEcCtD
Colestipol—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000823	0.000823	CcSEcCtD
Colestipol—Urticaria—Methotrexate—systemic scleroderma	0.000799	0.000799	CcSEcCtD
Colestipol—Dizziness—Prednisone—systemic scleroderma	0.000796	0.000796	CcSEcCtD
Colestipol—Abdominal pain—Methotrexate—systemic scleroderma	0.000795	0.000795	CcSEcCtD
Colestipol—Vomiting—Prednisone—systemic scleroderma	0.000765	0.000765	CcSEcCtD
Colestipol—Rash—Prednisone—systemic scleroderma	0.000759	0.000759	CcSEcCtD
Colestipol—Dermatitis—Prednisone—systemic scleroderma	0.000758	0.000758	CcSEcCtD
Colestipol—Headache—Prednisone—systemic scleroderma	0.000754	0.000754	CcSEcCtD
Colestipol—Hypersensitivity—Methotrexate—systemic scleroderma	0.000741	0.000741	CcSEcCtD
Colestipol—Asthenia—Methotrexate—systemic scleroderma	0.000722	0.000722	CcSEcCtD
Colestipol—Nausea—Prednisone—systemic scleroderma	0.000715	0.000715	CcSEcCtD
Colestipol—Diarrhoea—Methotrexate—systemic scleroderma	0.000688	0.000688	CcSEcCtD
Colestipol—Dizziness—Methotrexate—systemic scleroderma	0.000665	0.000665	CcSEcCtD
Colestipol—Vomiting—Methotrexate—systemic scleroderma	0.00064	0.00064	CcSEcCtD
Colestipol—Rash—Methotrexate—systemic scleroderma	0.000634	0.000634	CcSEcCtD
Colestipol—Dermatitis—Methotrexate—systemic scleroderma	0.000634	0.000634	CcSEcCtD
Colestipol—Headache—Methotrexate—systemic scleroderma	0.00063	0.00063	CcSEcCtD
Colestipol—Nausea—Methotrexate—systemic scleroderma	0.000598	0.000598	CcSEcCtD
